Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. ALERTS, HOT STOCKS & CHARTS Message Board

TEAR News Groundbreaking Osmolarity Prevalence

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 145158
Posted On: 04/23/2012 11:26:09 AM
Avatar
Posted By: lucyinthesky



TEAR News Groundbreaking Osmolarity Prevalence Study Presented at ASCRS 2012



2012-04-23 11:15 ET - News Release


 



SAN DIEGO, April 23, 2012 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) ("TearLab" or the "Company") announced that, today at the American Society of Cataract and Refractive Surgery 2012 Annual Meeting in Chicago, IL, prominent LASIK surgeon, Dr. Eric Donnenfeld, presented an interim analysis from a multicenter study designed to determine the overall prevalence of normal and abnormal tear fluid osmolarity in the patient population of clinicians who use the TearLab® Osmolarity System.


Normal tear film is in homeostasis with blood osmolarity at a reference value of 290 mOsm/L, with a normal "homeostatic range" for tear osmolarity defined as 275 - 307 mOsm/L. Hyperosmolarity is defined as a tear fluid osmolarity value in excess of the homeostatic range (greater or equal to 308 mOsm/L) in one or both eyes, and is used as a benchmark of dry eye disease ("DED"). 


The study involved 1,019 adult subjects (647 female, 372 male) from 16 sites across the United States and Europe. All patients in the study demonstrated at least three of the following nine binary symptoms: fluctuating vision, contact lens discomfort, light sensitivity, watery eyes, tired eyes, redness, burning, itching and sand or grit. 


The overall incidence of hyperosmolarity amongst the study population was 43.4%. Importantly, of the 42.4% of subjects who reported symptoms of DED, just 47.7% actually had the disease while 52.3% had some other form of ocular irritation. Conversely, of the 57.6% of study subjects that were asymptomatic, 40.2% actually had mild-to-moderate DED while 59.8% were within the normal homeostatic range.


Dr. Donnenfeld commented, "It has long been recognized that patient symptoms do not correlate with DED or disease severity. These findings confirm that. Patients may be asymptomatic for DED, but still present with hyperosmolarity. The good news is that eye doctors now have an objective tool to assess tear film health. Identification of asymptomatic DED by performing TearLab Osmolarity testing is particularly important prior to contact lens wear and before LASIK or cataract surgery as a dysfunctional tear film may pose a health risk and/or negatively impact surgical outcomes."




(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us